ZERO WINTERDEAL 2025: Bis zu 300 € Prämie + Gratis-Aktie + finanzen.net MSCI World-ETF - Jetzt informieren!

Lam Research Q1 Earnings Surpass Expectations, Revenues Rise Y/Y

23.10.25 15:50 Uhr

Werte in diesem Artikel
Aktien

130,38 EUR 6,92 EUR 5,61%

36,00 JPY 2,00 JPY 5,88%

Indizes

25.358,2 PKT 260,8 PKT 1,04%

23.204,9 PKT 263,1 PKT 1,15%

1.854,4 PKT -8,4 PKT -0,45%

6.791,7 PKT 53,3 PKT 0,79%

Lam Research (LRCX) reported first-quarter fiscal 2026 results, wherein both top and bottom lines surpassed the Zacks Consensus Estimate.LRCX reported first-quarter non-GAAP earnings of $1.26 per share, which beat the Zacks Consensus Estimate by 4.1%. The bottom line increased 46.5% on a year-over-year basis.In the first quarter of fiscal 2026, LRCX reported revenues of $5.32 billion, which surpassed the consensus mark by 2%. The top line increased 28% from the year-ago quarter’s $4.17 billion.Lam Research Corporation Price, Consensus and EPS Surprise Lam Research Corporation price-consensus-eps-surprise-chart | Lam Research Corporation QuoteLRCX’s Q1 Revenues in DetailLam Research’s Systems revenues were $3.55 billion (66.6% of total revenues), up 3% from the previous quarter and 48% year over year. Our model estimate for Systems revenues was pegged at $3.43 billion.In the Customer Support Business Group, revenues were $1.77 billion, comprising 33.4% of total revenues. This marks a 2.5% rise from the previous quarter’s $1.73 billion, and a 0.1% increase from the year-ago period. Our model estimate for Customer Support Business Group revenues was pegged at $1.79 billion.During the quarter, China contributed 43% of total revenues, Taiwan 19%, and Korea 15%. Other regions included Japan 10%, the United States 6%, Southeast Asia 5%, and Europe 2%.Operating Details of LRCXLam Research’s non-GAAP gross margin rose to 50.6%, up 30 basis points from 50.3% in the previous quarter.Non-GAAP operating expenses increased to $831.92 million, up 1.2% from $822.38 million. As a percentage of revenues, non-GAAP operating expenses declined to 15.6% in the first quarter from 15.9% in the fourth quarter.As a result, the non-GAAP operating margin improved 60 basis points sequentially to 35%.LRCX’s Balance Sheet & Cash FlowAs of Sept. 28, 2025, Lam Research held $6.69 billion in cash and cash equivalents, up from $6.39 billion at the end of the prior quarter.Cash flow from operating activities decreased significantly to $1.78 billion, down from $2.55 billion in the previous quarter.During the quarter, Lam Research paid dividends totalling $291.9 million and repurchased shares worth $975.8 million.LRCX Provides Strong GuidanceFor the second quarter of fiscal 2026, Lam Research projects revenues of $5.2 billion (+/- $300 million). The Zacks Consensus Estimate for the fiscal second quarter is pegged at $4.81 billion, indicating year-over-year growth of 9.8%.The company expects a non-GAAP gross margin of 48.5% (+/-1%) and a non-GAAP operating margin of 33% (+/-1%).Non-GAAP earnings per share are projected to be $1.15 (+/- $0.10), with a diluted share count of 1.26 billion. The Zacks Consensus Estimate for the fiscal second quarter is pegged at $1.05 per share, indicating year-over-year growth of 15.4%.Zacks Rank and Other Stocks to ConsiderCurrently, LRCX carries a Zacks Rank #2 (Buy).Impinj (PI), Credo Technology Group (CRDO) and Ambarella (AMBA) are some other top-ranked stocks that investors can consider in the Zacks Computer and Technology sector. Impinj and Credo Technology Group sport a Zacks Rank #1 (Strong Buy) each, while Ambarella carries a Zacks Rank #2 at present. You can see the complete list of today’s Zacks #1 Rank stocks here.The Zacks Consensus Estimate for Impinj’s full year 2025 earnings is pegged at $1.98 per share, revised upward by 4 cents over the past 60 days and suggests a year-over-year decline of 6.2%. Impinj shares have soared 39.2% year to date.The Zacks Consensus Estimate for Credo Technology Group’s fiscal 2026 earnings has been revised upward by 37.2% over the past 60 days to $2.03 per share, suggesting an increase of 190% year-over-year. Credo Technology Group shares have rallied 104.2% year to date.The Zacks Consensus Estimate for Ambarella’s fiscal 2026 earnings has been revised upwards to 50 cents per share from 13 cents 60 days ago, reflecting 412.5% year-over-year growth. Ambarella shares have risen 9.7% year to date.Radical New Technology Could Hand Investors Huge GainsQuantum Computing is the next technological revolution, and it could be even more advanced than AI.While some believed the technology was years away, it is already present and moving fast. Large hyperscalers, such as Microsoft, Google, Amazon, Oracle, and even Meta and Tesla, are scrambling to integrate quantum computing into their infrastructure.Senior Stock Strategist Kevin Cook reveals 7 carefully selected stocks poised to dominate the quantum computing landscape in his report, Beyond AI: The Quantum Leap in Computing Power.Kevin was among the early experts who recognized NVIDIA's enormous potential back in 2016. Now, he has keyed in on what could be "the next big thing" in quantum computing supremacy. Today, you have a rare chance to position your portfolio at the forefront of this opportunity.See Top Quantum Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Lam Research Corporation (LRCX): Free Stock Analysis Report Ambarella, Inc. (AMBA): Free Stock Analysis Report Impinj, Inc. (PI): Free Stock Analysis Report Credo Technology Group Holding Ltd. (CRDO): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Lam Research und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Lam Research

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Lam Research

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Lam Research Corp.

Wer­bung

Analysen zu Lam Research Corp.

DatumRatingAnalyst
25.04.2019Lam Research OutperformCowen and Company, LLC
22.04.2019Lam Research BuyB. Riley FBR
24.01.2019Lam Research OutperformCowen and Company, LLC
21.12.2018Lam Research BuyNeedham & Company, LLC
29.10.2018Lam Research NeutralB. Riley FBR
DatumRatingAnalyst
25.04.2019Lam Research OutperformCowen and Company, LLC
22.04.2019Lam Research BuyB. Riley FBR
24.01.2019Lam Research OutperformCowen and Company, LLC
21.12.2018Lam Research BuyNeedham & Company, LLC
17.10.2018Lam Research OutperformCowen and Company, LLC
DatumRatingAnalyst
29.10.2018Lam Research NeutralB. Riley FBR
01.10.2018Lam Research HoldDeutsche Bank AG
01.10.2018Lam Research NeutralMizuho
12.10.2016Lam Research Sector WeightPacific Crest Securities Inc.
21.04.2015Lam Research Sector PerformRBC Capital Markets
DatumRatingAnalyst
22.10.2015Lam Research UnderperformRBC Capital Markets
05.10.2015Lam Research UnderperformRBC Capital Markets
11.11.2010Lam Research sellCitigroup Corp.
29.07.2010Lam Research sellCitigroup Corp.
19.03.2009Lam Research underperformCredit Suisse Group

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Lam Research Corp. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen